Company / Total Assets
Revolution Medicines, Inc. Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$2.4B
FY2025
5-year range
$738.0M / $2.6B
FY2021-FY2025
Trend
-8.0%
vs FY2024
Sector context
#39 of 214
Health Care
What the data says
Revolution Medicines, Inc.'s total assets of $2.4B is higher than 82% of companies in the Health Care sector (FY2025). Improved from $2.1B to $2.4B over the past 2 years.
Based on SEC 10-K filings.
$2.4B in FY2025 with a 5-year CAGR of +32.9%. Top quartile in the Health Care sector.
Improved from $2.1B to $2.4B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +42.6%
- 5-Year CAGR
- +32.9%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 214This company $2.4B Sector average $7.5B
▼
-68.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +32.9%, indicating consistent growth.
- In FY2025, total assets decreased 8.0% year-over-year.
- Ranks #39 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.4B | -8.0% |
| FY2024 | $2.6B | +24.1% |
| FY2023 | $2.1B | +153.9% |
| FY2022 | $811.9M | +10.0% |
| FY2021 | $738.0M | +30.1% |
| FY2020 | $567.4M | +157.3% |
| FY2019 | $220.5M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026